These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Fluorenone and benzophenone 1,4-dihydropyridine derivatives with cardiodepressant activity. Rampa A; Budriesi R; Bisi A; Chiarini A; Valenti P Arzneimittelforschung; 1992 Nov; 42(11):1284-7. PubMed ID: 1492840 [TBL] [Abstract][Full Text] [Related]
4. SAR studies in the field of Ca-antagonists: 2-substituted 1,4-dihydropyridines with a xanthone backbone. Bisi A; Budriesi R; Chiarini A; Rampa A; Valenti P Farmaco; 1993 Nov; 48(11):1491-502. PubMed ID: 8110362 [TBL] [Abstract][Full Text] [Related]
5. Structure-activity relationship studies in the field of calcium antagonists. Xanthone 1,4-dihydropyridines bearing a 2,3-lactone ring. Rampa A; Budriesi R; Bisi A; Fabbri G; Barili PL; Chiarini A; Valenti P Arzneimittelforschung; 1995 Sep; 45(9):957-62. PubMed ID: 7488312 [TBL] [Abstract][Full Text] [Related]
6. Synthesis and pharmacological characterization of some benzazepinone derivatives. Budriesi R; Rampa A; Bisi A; Fabbri G; Chiarini A; Valenti P Arzneimittelforschung; 1995 Mar; 45(3):234-9. PubMed ID: 7741775 [TBL] [Abstract][Full Text] [Related]
7. Synthesis and cardiovascular properties of furazanyl-1,4-dihydropyridines and of furoxanyl analogues. Gasco AM; Fruttero R; Sorba G; Gasco A; Budriesi R; Chiarini A Arzneimittelforschung; 1992 Jul; 42(7):921-5. PubMed ID: 1418057 [TBL] [Abstract][Full Text] [Related]
14. 1,4-Dihydropyridine derivatives as calcium channel modulators: the role of 3-methoxy-flavone moiety. Budriesi R; Bisi A; Ioan P; Rampa A; Gobbi S; Belluti F; Piazzi L; Valenti P; Chiarini A Bioorg Med Chem; 2005 May; 13(10):3423-30. PubMed ID: 15848754 [TBL] [Abstract][Full Text] [Related]
15. Cardiovascular selectivity of 1,4-dihydropyridine derivatives, efonidipine (NZ-105), nicardipine and structure related compounds in isolated guinea-pig tissues. Masuda Y; Miyajima M; Shudo C; Tanaka S; Shigenobu K; Kasuya Y Gen Pharmacol; 1995 Mar; 26(2):339-45. PubMed ID: 7590084 [TBL] [Abstract][Full Text] [Related]
16. Cardiovascular hybrid drugs: new benzazepinone derivatives as bradycardic agents endowed with selective beta1-non-competitive antagonism. Bisi A; Rampa A; Budriesi R; Gobbi S; Belluti F; Ioan P; Valoti E; Chiarini A; Valenti P Bioorg Med Chem; 2003 Apr; 11(7):1353-61. PubMed ID: 12628661 [TBL] [Abstract][Full Text] [Related]
17. Long-acting dihydropyridine calcium antagonists. 3. Synthesis and structure-activity relationships for a series of 2-[(heterocyclylmethoxy)methyl] derivatives. Alker D; Campbell SF; Cross PE; Burges RA; Carter AJ; Gardiner DG J Med Chem; 1989 Oct; 32(10):2381-8. PubMed ID: 2795609 [TBL] [Abstract][Full Text] [Related]
18. Biological activities of novel thienothiazine derivatives on heart and smooth muscle preparations of guinea pigs. Studenik C; Lemmens-Gruber R; Heistracher P Arzneimittelforschung; 1999 Sep; 49(9):740-4. PubMed ID: 10514900 [TBL] [Abstract][Full Text] [Related]
19. Comparative determination of the cardioselectivity of taxine and verapamil in the isolated aorta, atrium and jejunum preparations of rabbits. Tekol Y; Göğüsten B Arzneimittelforschung; 1999 Aug; 49(8):673-8. PubMed ID: 10483513 [TBL] [Abstract][Full Text] [Related]
20. Pharmacological in vitro studies of the new 1,4-dihydropyridine calcium antagonist lercanidipine. Guarneri L; Angelico P; Ibba M; Poggesi E; Taddei C; Leonardi A; Testa R Arzneimittelforschung; 1996 Jan; 46(1):15-24. PubMed ID: 8821512 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]